New Report on Estradiol Ranges in Postmenopausal Women Released

Updated recommendations to establish normal estradiol reference ranges have been released in a new report from the North American Menopause Society (NAMS).

The report is based on a symposium called “Workshop on Normal Reference Ranges for Estradiol in Postmenopausal Women,” that was held in September 2019, in Chicago, Ill., and featured 28 presentations. The Endocrine Society and the Partnership for the Accurate Testing of Hormones (PATH) were supporters of this symposium.

PATH was established in 2010 to help the clinical, medical, and public health communities improve patient care through more accurate and reliable hormone tests. Improved patient care through the universal use of accurate and reliable hormone tests in healthcare and research is PATH’s chief goal, which is why it was one of the participants in this workshop.

The overarching goal of the symposium was to review existing analytical methodologies for measuring estradiol in postmenopausal women and to assess existing data and study cohorts of postmenopausal women for their suitability to establish normal postmenopause reference ranges.

The anticipated outcome of the workshop was to develop recommendations for establishing normal reference ranges generated with a standardized and certified assay that could be adopted by clinical and research communities.

Aside from the Endocrine Society and PATH, the other organizations that lent support for the symposium include: NAMS, the American Society for Reproductive Medicine, the Centers for Disease Control and Prevention, the International Society for the Study of Women’s Sexual Health, the University of Virginia, Division of Endocrinology and Metabolism, and the International Menopause Society.

Funding companies for the workshop included: Abbott Laboratories, Ansh Labs, ARUP Labs, Endoceutics, Novo Nordisk, Quest Diagnostics, and TherapeuticsMD.

The report from the workshop is published in the June 2020 issue of Menopause. More information about accurate hormone assays and PATH is available at www.hormoneassays.org.

 

You may also like

  • Destination Albuquerque: Previewing the 1st International Conference on Steroid Hormones and Receptors

    Building on a legacy that has lasted for a quarter of a century and now sponsored by the Endocrine Society, the 1st International Conference on Steroid Hormones and Receptors will be held next month at University of New Mexico Comprehensive Cancer Center in Albuquerque. Endocrine News talks to conference chairs Eric R. Prossnitz, PhD, and…

  • Meet New Endocrine Society President, John Newell-Price, MD, PhD

    The Endocrine Society is pleased to welcome its president for 2024 – 2025, John Newell-Price, MD, PhD, FRCP, who took office during ENDO 2024 in Boston. Newell-Price is Professor of Endocrinology at the University of Sheffield, United Kingdom. He is also head of the Endocrinology Service at Sheffield Teaching Hospitals NHS Foundation Trust and of…

Find more in